Skip to content
Dermatological Compounding Course | September 18–19, 2026
Dermatological Compounding is a live, practice-focused training course designed for pharmacists, pharmacy technicians, and pharmacy professionals involved in the preparation of customized topical therapies. This program provides an in-depth review of skin pathophysiology, dermatologic disease states, topical dosage forms, and formulation strategies to support patient-specific treatment.
Participants will examine common dermatological conditions, including eczema, dermatitis, psoriasis, and inflammatory skin disorders, with discussion of disease mechanisms and therapeutic goals. Instruction emphasizes selecting appropriate dosage forms and bases based on skin type, lesion characteristics, and patient preference.
The course explores topical drug therapy options, including corticosteroids, calcineurin inhibitors, keratolytics, emollients, anesthetics, and combination formulations. Attendees will review drug stability, penetration, potency considerations, and excipient selection to optimize safety and effectiveness.
A dedicated component addresses compounded topical pain management, including evaluation of pain types, pharmacologic targets, and formulation strategies that support localized therapy while minimizing systemic exposure.
This program blends clinical knowledge and practical application, equipping participants with the skills and confidence to compound dermatologic preparations that meet individual patient needs while maintaining quality and safety standards.
Strengthen your dermatological compounding skills with this live, hands-on course focused on customized topical therapies and patient-centered care.
What attendees said:
- “The course was highly informative and provided a rich set of materials and resources that support pharmacists looking to elevate their compounding practice.”
- “The content was practical and easy to apply, with clear explanations that strengthened my confidence in dermatological compounding.”
- “The depth of information and real-world examples made this course both engaging and highly beneficial.”
The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this knowledge/application-based program for 15 contact hours (1.5 CEUs) of continuing education credit for pharmacists and pharmacy technicians.
Register of Historic Places and is world-famous for its five resident Mallard ducks, who march daily through the lobby at 11am and 5pm.
Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA is a pharmacist-attorney in Frier Levitt’s Life Sciences Department. She is also a registered patent attorney and leads the firm’s Intellectual property team. She has broad and in-depth healthcare and regulatory experience. Her practice focuses on intellectual property (patents, trademarks, copyrights, trade secrets) and healthcare law, Food, Drug, Device & Cosmetic law (all facets-483s to clinical trials to registrations and product approval), pharmacy law and regulatory issues, 503A/503B compounding, Board of Pharmacy (licensing and disciplinary matters), PBM audits, and DSCSA supply chain compliance. Dr. Rumore has over 25 years of health-system, pharmaceutical industry, and law firm experience in the area of Food, Drug & Cosmetic Law, and pharmaceutical intellectual property Dr. Rumore is fluent in cGMPs, GCPs, writing and reviewing Clinical Trial Agreements (CTAs), Investigator brochures, manuscripts, labeling & advertising review, NDAs, study reports, and documents for regulatory submissions. She often prepares legal memoranda on healthcare/FDA matters and conducts Mock State Board of Pharmacy and FDA inspections for compounding pharmacies. Dr. Rumore has practiced both pharmacy and law. She has actual experience as a compounding pharmacist. She regularly counsels on Section 503A and state-specific compounding requirements, assesses compounding practices for state and federal regulatory compliance, including USP 797/795/800, medical necessity documentation, advertising & promotion, reimbursement issues, infrastructure, and preparing compounding policies and procedures that provide clear guidelines, standards, and training for staff. Previously, she was at the Director level in Drug Regulatory Affairs/Compliance in the pharmaceutical industry and hospital pharmacy. She taught Pharmacy Law, Drug Regulatory Affairs, and Food Drug & Cosmetic Law at several New York Colleges of Pharmacy and currently teaches Food, Drug & Cosmetic Law at Maurice A. Deane School of Law at Hofstra University. She is a frequent lecturer and has over 200 publications and presentations.
